Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $332B |
| FY2017, ended Dec 31, 2017 | $513B |
| FY2018, ended Dec 31, 2018 | $374B |
| FY2019, ended Dec 31, 2019 | $585B |
| FY2020, ended Dec 31, 2020 | $778B |
| FY2021, ended Dec 31, 2021 | $916B |
| FY2022, ended Dec 31, 2022 | $312B |
| FY2023, ended Dec 31, 2023 | $902B |
| FY2024, ended Dec 31, 2024 | $1.48T |
| FY2025, ended Dec 31, 2025 | $1.67T |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.85T |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.6B |
| FY2017, ended Dec 31, 2017 | $40.7B |
| FY2018, ended Dec 31, 2018 | $55.8B |
| FY2019, ended Dec 31, 2019 | $70.7B |
| FY2020, ended Dec 31, 2020 | $86.0B |
| FY2021, ended Dec 31, 2021 | $118B |
| FY2022, ended Dec 31, 2022 | $117B |
| FY2023, ended Dec 31, 2023 | $135B |
| FY2024, ended Dec 31, 2024 | $165B |
| FY2025, ended Dec 31, 2025 | $201B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $242B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $10.2B | $11.6B |
| FY2017, ended Dec 31, 2017 | $15.9B | $17.5B |
| FY2018, ended Dec 31, 2018 | $22.1B | $15.4B |
| FY2019, ended Dec 31, 2019 | $18.5B | $21.2B |
| FY2020, ended Dec 31, 2020 | $29.1B | $23.6B |
| FY2021, ended Dec 31, 2021 | $39.4B | $39.0B |
| FY2022, ended Dec 31, 2022 | $23.2B | $19.3B |
| FY2023, ended Dec 31, 2023 | $39.1B | $44.1B |
| FY2024, ended Dec 31, 2024 | $62.4B | $54.1B |
| FY2025, ended Dec 31, 2025 | $60.5B | $46.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $75.2B | $28.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.90B |
| FY2017, ended Dec 31, 2017 | $8.08B |
| FY2018, ended Dec 31, 2018 | $10.0B |
| FY2019, ended Dec 31, 2019 | $19.1B |
| FY2020, ended Dec 31, 2020 | $17.6B |
| FY2021, ended Dec 31, 2021 | $16.6B |
| FY2022, ended Dec 31, 2022 | $14.7B |
| FY2023, ended Dec 31, 2023 | $41.9B |
| FY2024, ended Dec 31, 2024 | $43.9B |
| FY2025, ended Dec 31, 2025 | $35.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $11.2B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $0 |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | $0 |
| FY2022, ended Dec 31, 2022 | $9.92B |
| FY2023, ended Dec 31, 2023 | $18.4B |
| FY2024, ended Dec 31, 2024 | $28.8B |
| FY2025, ended Dec 31, 2025 | $58.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $83.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 11.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.89B |
| FY2017, ended Dec 31, 2017 | 2.91B |
| FY2018, ended Dec 31, 2018 | 2.85B |
| FY2019, ended Dec 31, 2019 | 2.85B |
| FY2020, ended Dec 31, 2020 | 2.85B |
| FY2021, ended Dec 31, 2021 | 2.72B |
| FY2022, ended Dec 31, 2022 | 2.59B |
| FY2023, ended Dec 31, 2023 | 2.55B |
| FY2024, ended Dec 31, 2024 | 2.53B |
| FY2025, ended Dec 31, 2025 | 2.53B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 2.56B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $3.22B | $74.0M |
| FY2017, ended Dec 31, 2017 | $1.98B | $3.72B | $323M |
| FY2018, ended Dec 31, 2018 | $12.9B | $4.15B | — |
| FY2019, ended Dec 31, 2019 | $4.20B | $4.84B | — |
| FY2020, ended Dec 31, 2020 | $6.27B | $6.54B | — |
| FY2021, ended Dec 31, 2021 | $44.5B | $9.16B | — |
| FY2022, ended Dec 31, 2022 | $28.0B | $12.0B | — |
| FY2023, ended Dec 31, 2023 | $19.8B | $14.0B | — |
| FY2024, ended Dec 31, 2024 | $30.1B | $16.7B | — |
| FY2025, ended Dec 31, 2025 | $26.2B | $20.4B | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $0 | $26.9B | — |
Valuation
At current price- Market Cap
- $1.59T
- P/E
- 21.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.6×
- Price / Book
- 5.8×
- EV / EBITDA
- 15.9×
Growth
Trailing 12 months- Revenue (TTM)
- $242B
- Revenue Growth YoY
- 27.5%
- Revenue CAGR 3Y
- 19.9%
- Revenue CAGR 5Y
- 18.5%
- EPS Growth YoY
- 29.7%
- Net Income Growth YoY
- 28.6%
Profitability
Trailing 12 months- Gross Margin
- 81.0%
- Operating Margin
- 32.9%
- Net Margin
- 31.1%
- FCF Margin
- 11.9%
- Return on Equity
- 32.3%
Earnings
Trailing 12 months- Net Income
- $75.2B
- EPS (diluted)
- $29.31
- EBITDA
- $104B
- Operating Income
- $79.4B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $11.2B
- Total Debt
- $83.7B
- Net Debt
- $72.4B
- Total Assets
- $479B
- Total Liabilities
- $206B
- Shareholders' Equity
- $272B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $133B
- Capital Expenditure
- $104B
- Free Cash Flow
- $28.6B
Dividends and risk
Last 12 months- Dividend Yield
- 0.3%
- Dividend / Share
- $2.10
- Beta (5Y)
- 1.18
Every ratio is calculated from the company’s reported figures.